The impact of morbid obesity and bariatric surgery on comorbid conditions: A comprehensive examination of comorbidities in an employed population

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 2, 2009, Pages 170-179

  Kleinman, Nathan L ^a   Melkonian, Arthur ^a   Borden, Spencer ^b   Rohrbacker, Nicholas ^a   Lynch, Wendy D ^a   Gardner, Harold H ^a  

^a Human Capital Management Services   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMPLOYEE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MORBID OBESITY; PREVALENCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WEIGHT REDUCTION; EMPLOYMENT; RISK FACTOR; UNITED STATES;

ADULT; BARIATRIC SURGERY; COMORBIDITY; EMPLOYMENT; FEMALE; HUMANS; MALE; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 67449093475     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31818def04     Document Type: Article

References (56)

1. Zimmerman-Belsing T, Feldt-Rasmussen U. Obesity: the new worldwide epidemic threat to general health and our complete lack of effective treatment. Endocrinology. 2004;145:1501-1502.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States. Endocrinology. 2006;145:1549-1555.
3. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes. 2003;27:1167-1177.
4. Martinez-Owens T. Morbid obesity: the disease and the comorbidities. Crit Care Nurs Q. 2003;26:162-165.
5. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465-1475.
6. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106:493- 499.
7. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917-932.
8. Brook RA, Wahlqvist P, Kleinman NL, Wallander MA, Campbell SM, Smeeding JE. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Aliment Pharmacol Ther. 2007;26:889-898.
9. Gonzalez ER. Pharmacoeconomic benefits of antihypertensive therapy. J Manag Care Pharm. 2007;13:S20-S21.
10. Petry NM, Barry D, Pietrzak RH, Wagner JA. Overweight and obesity are associated with psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Psychosom Med. 2008;70:288-297.
11. Sutherland ER. Obesity and asthma. Immunol Allergy Clin North Am. 2008;28: 589-602.
12. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
13. Fass R. The pathophysiological mechanisms of GERD in the obese patient. Dig Dis Sci. 2008;53:2300-2306.
14. Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesityrelated illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189: 27-32.
15. Schauer PR, Bartolome B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-485.
16. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240:416-424.
17. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomized controlled trial. JAMA. 2008;299: 316-323.
18. Basham P, Luik J, Jeffery RW, Sherwood NE. Is the obesity epidemic exaggerated? BMJ. 2008;336:241-245.
19. Martin LF, Smits GJ, Greenstein RJ. Treating morbid obesity with laparoscopic adjustable gastric banding. Am J Surg. 2007;194:333-343.
20. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132:2253-2271.
21. Nelson WK, Fatima J, Houghton SG, Thompson GB, et al. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery. 2006;140:517-523.
22. Crookes PF. Surgical treatment of morbid obesity. Annu Rev Med. 2006;57: 243-264.
23. Hager C. Quality of life after Roux-en Y gastric bypass surgery. AORN. 2007;85: 768-778.
24. Gould JC, Garren MJ, Boll V, Starling JR. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients. Surgery. 2006;140:524-531.
25. Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev. 2005; 4:CD003641.
26. Kleinman NL, Brook RA, Rajagopalan K, Gardner HH, Brizee TA, Smeeding JE. Lost time, absence costs, and reduced productivity output for employees with bipolar disorder. J Occup Environ Med. 2005;47:1117-1124.
27. Rajagopalan K, Kleinman NL, Brook RA, Gardner HH, Brizee TA, Smeeding JE. Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder. Curr Med Res Opin. 2006;22:443-452.
28. Brook RA, Rajagopalan K, Kleinman NL, Smeeding JE, Brizee TA, Gardner HH. Incurring greater health care costs: risk stratification of bipolar disorder employees. Prim Care Companion J Clin Psychiatry. 2006;8:17-24.
29. Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, Joseph-Ridge N. The economic burden of gout in an employed population. Curr Med Res Opin. 2006;22:1381-1389.
30. Gardner HH, Kleinman NL, Brook RA, Rajagopalan K, Brizee TA, Smeeding JE. The impact of bipolar disorder on an employed population. J Clin Psychiatry. 2006;67:1209-1218.
31. Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA. Prevalence of gout with comorbid metabolic and cardiovascular conditions and medical services associated with these conditions in a managed care setting. Curr Med Res Opin. 2007;23: 623-630.
32. Brook RA, Kleinman NL, Rajagopalan K. Employee costs before and after treatment initiation for bipolar disorder. Am J Manag Care. 2007;13:179-186.
33. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health. 2007;10: 231-237.
34. Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software. US Agency for Healthcare and Research. Available at: http://www.hcup-us.ahrq.gov/ reports/ methods.jsp. Accessed December 2006.
35. Kosanke J, Bergstralh E. SAS GMATCH Macro. 2004. Available at: http:// mayoresearch.mayo.edu/mayo/research/ biostat/sasmacros.cfm. Accessed November 1, 2007.
36. Jewell N. Statistics for Epidemiology. Boca Raton: Chapman and Hall; 2004.
37. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237: 751-758.
38. Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low AK, Land KK. The effect of obesity surgery on obesity comorbidity. Am J Med Sci. 2006;331:183-193.
39. Li Z, Bowerman S, Hever D. Health ramifications of the obesity epidemic. Surg Clin N Am. 2005;85:681-701.
40. Bray GA. Medical consequences of obesity. J Clin Endocrin Metab. 2004;89: 2583-2589.
41. Young SY, Gunzenhauser JD, Malone KE, McTiernan A. Body mass index and asthma in the military population of the northwestern United States. Arch Intern Med. 2001;161:1605-1611.
42. Hensrud HD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc. 2006;82(10 suppl):S5-S10.
43. Mathier MA, Ramanathan RC. Impact of obesity and bariatric surgery on cardiovascular disease. Med Clin N Am. 2007; 91:415-431.
44. Finer N. Obesity. Clin Med. 2003;3:23-27.
45. Linde JA, Jeffery RW, Finch EA, et al. Relation of body mass index to depression and weighing frequency in overweight women. Prev Med. 2007;45:75-79.
46. Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003; 158:1139-1147.
47. Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ. Are the obese at greater risk for depression? Am J Epidemiol. 2000;152:163-170.
48. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292: 1724-1737.
49. Weber M, Miller MK, Bucher T, et al. Laparoscopic bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004;240: 975-983.
50. Cawley J, Prinz T, Beane S. Health insurance claims data as a means of assessing reduction in co-morbidities 6 months after bariatric surgery. Obes Surg. 2006; 16:852-858.
51. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg. 2002;184:51S-54S.
52. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
53. Birnbaum H, Morley M, Leong S, Greenberg P, Colice G. Lower respiratory tract infections: impact on the workplace. Pharmacoeconomics. 2003;21:749-759.
54. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
55. Turner JA, Franklin G, Fulton-Kehoe D, et al. Prediction of chronic disability in work-related musculoskeletal disorders: a prospective, population-based study. BMC Musculoskelet Disord. 2004;5:14.
56. Keyserling WM. Workplace risk factors and occupational musculoskeletal disorders, part 1: a review of biomechanical and psychophysical research on risk factors associated with low-back pain. AIHAJ. 2000;61:39-50.